Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.31%
EBIT Growth (5y)
4.44%
EBIT to Interest (avg)
22.33
Debt to EBITDA (avg)
1.18
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.79
Tax Ratio
31.54%
Dividend Payout Ratio
0
Pledged Shares
13.75%
Institutional Holding
41.48%
ROCE (avg)
13.54%
ROE (avg)
9.95%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
37
Price to Book Value
2.52
EV to EBIT
17.81
EV to EBITDA
13.13
EV to Capital Employed
2.63
EV to Sales
2.66
PEG Ratio
2.01
Dividend Yield
NA
ROCE (Latest)
14.23%
ROE (Latest)
9.37%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(Q)
Highest at Rs 9,150.35 cr
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 9,870.29 cr
DEBT-EQUITY RATIO(HY)
Lowest at 0.21 times
PBDIT(Q)
Highest at Rs 1,881.06 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 20.56%
PBT LESS OI(Q)
Highest at Rs 1,291.04 cr.
PAT(Q)
Highest at Rs 1,059.93 cr.
EPS(Q)
Highest at Rs 17.95
-4What is not working for the Company
ROCE(HY)
Lowest at 12.10%
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.71 times
Loading Valuation Snapshot...
Here's what is working for Aurobindo Pharma
Net Sales - Quarterly
Highest at Rs 9,150.35 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,881.06 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 20.56%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1,291.04 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1,059.93 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 17.95
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 9,870.29 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Lowest at 0.21 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Aurobindo Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 4.71 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 264.23 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
